8 April 2021
After a year of unprecedented challenges from the coronavirus (COVID-19) spread around the world and large swings in investor sentiment globally, the March 2021 quarter was noteworthy for renewed hope and optimism as the global COVID-19 case rate decreased and viable COVID vaccines began to be rolled out worldwide with bio-medical companies scaling-up production to meet demand.
31 March 2021
Volumes in the Vanguard Global Value Equity Active ETF (VVLU) are on the rise coinciding with the re-opening of global economies, positive GDP growth and prospects of a reflation trade.
29 March 2021
PMV announced a strong 1H21 result ahead vs its 13 January update, with EBIT (pre-AASB16) lifting 88.5% vs pcp to $237.8m (vs guidance $221m-$233m).